OpenAI introduces ChatGPT for clinicians

OpenAI has introduced ChatGPT for Clinicians, a version of ChatGPT designed to support clinical tasks such as documentation and medical research, with free access for verified physicians, nurse practitioners, physician assistants, and pharmacists in the US.

The company said the launch comes as clinicians face increasing administrative demands alongside a growing volume of medical research. According to a 2026 survey by the American Medical Association, 72% of physicians reported using AI in clinical practice, up from 48% the previous year. OpenAI said millions of clinicians worldwide already use ChatGPT weekly for care consults, writing and documentation, and medical research, with clinician usage more than doubling over the past year.

Earlier this year, OpenAI introduced ChatGPT for Healthcare, an enterprise product for organizations to deploy ChatGPT across clinicians, administrators, and researchers with compliance and administrative controls. The company said ChatGPT for Clinicians is the next step in expanding access.

The platform includes access to advanced AI models for clinical questions, reusable workflow tools for tasks such as referral letters and prior authorizations, real-time cited clinical search based on peer-reviewed medical sources, literature review support across medical journals, and continuing medical education credit opportunities tied to eligible evidence reviews. Optional HIPAA compliance support is available through a Business Associate Agreement for eligible accounts, and conversations are not used to train models.

“This version of ChatGPT is as close to an ideal clinical support partner as it gets,” said Albert, an internal medicine and cardiology physician advisor, in the release. “It’s like an on-demand consultant I can engage on everything from current guidelines to billing and coding, with the added benefit of broad access to pediatric and pediatric subspecialty literature.”

OpenAI said it worked with hundreds of physician advisors to develop the product and continues to evaluate model performance through physician review. According to the company, physician advisors have reviewed more than 700,000 model responses for quality, reasoning, trustworthiness, and safety.

Before release, physician advisors tested 6924 conversations across clinical care, documentation, and research. OpenAI said physicians rated 99.6% of responses as safe and accurate. In a subset of 355 examples where three independent physicians identified ground-truth citations, the company said ChatGPT for Clinicians cited those sources more often than human physicians.

The company emphasized that the tool is intended to support clinicians rather than replace their judgment.

Alongside the launch, OpenAI also introduced HealthBench Professional, an open benchmark for clinician chat tasks across care consults, writing and documentation, and medical research. The benchmark uses physician-authored conversations, physician adjudication, and filtered datasets to evaluate model performance and safety.

OpenAI reported that GPT-5.4 in the ChatGPT for Clinicians workspace outperformed base GPT-5.4, other OpenAI and external models, and physician-written responses on HealthBench Professional.

The free version of ChatGPT for Clinicians is currently available to verified US physicians, nurse practitioners, physician assistants, and pharmacists. OpenAI said it plans to expand access to additional countries and groups over time, beginning with a pilot through the Better Evidence Network for verified clinicians outside the United States, subject to local regulations.

The company also released a Health Blueprint with recommendations for responsible AI integration in US healthcare.

Reference:

1. Making ChatGPT better for clinicians. News release. ChatGPT. April 22, 2026. Accessed April 29, 2026. https://openai.com/index/making-chatgpt-better-for-clinicians/